Clindamycin compared with penicillin for the treatment of anaerobic lung abscess.
The clinical efficacy of clindamycin was compared with that of penicillin in a randomized study of the treatment of community-acquired putrid lung abscess. After starting therapy, patients treated with clindamycin had a shorter febrile period and fewer days of fetid sputum than patients treated with penicillin (mean 4.4 versus 7.6 days and 4.2 versus 8.0 days, respectively, p less than 0.05). Four of 20 patients treated with penicillin had clinically significant pulmonary or pleural extension of their infection within 10 days after starting therapy; this was not found in any of 19 patients treated with clindamycin (p less than 0.05). Penicillin treatment failed in two additional patients after 20 days of therapy. Within 1 month after treatment, 1 of 4 patients given penicillin for 3 weeks had relapse, but none of the 13 patients given clindamycin for 3 or 6 weeks, and none of the 5 patients given penicillin for 6 weeks had relapse. Overall, only 8 of 15 patients treated with penicillin who could be followed to the end of the study were cured, whereas all 13 patients treated with clindamycin who could be followed were cured (p less than 0.01). These results suggest that penicillin may not be optimal therapy for anaerobic lung abscess.
D000328:Adult; D000368:Aged; D000693:Anaerobiosis; D002981:Clindamycin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005334:Fever / Q000188:drug therapy; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010400:Penicillin G / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy; D011897:Random Allocation; D013183:Sputum / Q000187:drug effects
D002981:Clindamycin; D010400:Penicillin G